Compare Lumentum (LITE) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lumentum vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Lumentum trades at $1,104.77 (market cap $94.99B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.64 (market cap $2.27B). The key difference: Lumentum is far larger — about 41.8× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Lumentum is more actively traded (4,855,776 versus 4,179,659). Which is the better fit depends on your goals.
| LITE | SLS | |
|---|---|---|
Market Cap | $94.99B | $2.27B |
Volume | 4,855,776 | 4,179,659 |
Sector | Technology | Health |
52-Week High | $1.13K | $15.46 |
52-Week Low | $149.61 | $1.39 |
Typical Hold Time | 4 Days | — |
Enterprise Value | $93.92B | $2.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Lumentum
Lumentum develops photonic products, including optical components, transceivers, and lasers. Its technologies support data centers, communications networks, industrial manufacturing, and sensing applications.
Read more on LITE →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
